SYNTHESIS AND DOPAMINE RECEPTOR AFFINITIES OF 2-(4-FLUORO-3-HYDROXYPHENYL)ETHYLAMINE AND N-SUBSTITUTED DERIVATIVES

被引:22
作者
CLAUDI, F [1 ]
CARDELLINI, M [1 ]
CINGOLANI, GM [1 ]
PIERGENTILI, A [1 ]
PERUZZI, G [1 ]
BALDUINI, W [1 ]
机构
[1] UNIV URBINO,INST PHARMACOL & PHARMACOGNOSY,I-62029 URBINO,ITALY
关键词
D O I
10.1021/jm00171a014
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of 2-(4-fluoro-3-hydroxyphenyl)ethylamine (26) and of some A^TV-dialkyl derivatives (27–36) starting from 4-fluoro-3-hydroxytoluene and their in vitro binding affinities for dopamine (DA) receptor are reported. The amine 26 can be regarded as a molecular modification of DA in which the para hydroxyl group is replaced by fluorine. The new compounds 26–30 were evaluated for their affinity at D-l and D-2 DA receptor subtypes by displacement of [3H]SCH 23390 (D-l selective) and [3H]spiperone (D-2 selective). The amine 26 had about 2-fold less affinity for D-l and D-2 binding sites than DA. The substitution of the amino group with ethyl, n-propyl, and 2-phenylethyl groups decreased the affinity for D-l binding sites but greatly enhanced the effectiveness on D-2 binding sites. The N-ethyl- (28) and AT-n-propyl-.N-(2-phenylethyl)-2-(4-fluoro-3-hydroxyphenyl)ethylamine (30) were the most potent members of the series with high selectivity for D-2 binding sites. A similar effect was observed with isomeric,V-n-propyl-Ar-(2-phenylethyl)-2-(3-fluoro-4-hydroxyphenyl)ethylamine (31) which was approximately 65 times more selective for D-2 sites vs D-l sites, The introduction of a 2-phenylethyl group on the nitrogen atom induce the highest effect, perhaps as a consequence of an increased liposolubility or of binding to a complementary lipophilic site on the receptor. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:2408 / 2412
页数:5
相关论文
共 18 条
[1]  
Cannon J G, 1985, Prog Drug Res, V29, P303
[2]  
CARDELLINI M, 1988, FARMACO, V43, P49
[3]   SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF N,N-DI-N-PROPYLDOPAMINE CONGENERS CONTAINING PHENOLIC BIOISOSTERES [J].
CLARK, RD ;
CAROON, JM ;
ISAAC, NE ;
MCCLELLAND, DL ;
MICHEL, AD ;
PETTY, TA ;
ROSENKRANZ, RP ;
WATERBURY, LD .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (05) :411-415
[4]   SYNTHESES AND INVITRO EVALUATION OF 4-(2-AMINOETHYL)-2(3H)-INDOLONES AND RELATED-COMPOUNDS AS PERIPHERAL PREJUNCTIONAL DOPAMINE RECEPTOR AGONISTS [J].
DEMARINIS, RM ;
GALLAGHER, G ;
HALL, RF ;
FRANZ, RG ;
WEBSTER, C ;
HUFFMAN, WF ;
SCHWARTZ, MS ;
KAISER, C ;
ROSS, ST ;
WILSON, JW ;
HIEBLE, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (06) :939-947
[5]   ACTIVITY OF 2 NEW POTENT DOPAMINERGIC AGONISTS AT THE STRIATAL AND ANTERIOR-PITUITARY LEVELS [J].
EUVRARD, C ;
FERLAND, L ;
DIPAOLO, T ;
BEAULIEU, M ;
LABRIE, F ;
OBERLANDER, C ;
RAYNAUD, JP ;
BOISSIER, JR .
NEUROPHARMACOLOGY, 1980, 19 (04) :379-386
[6]   SYNTHESIS AND EVALUATION OF THE ANTI-OVULATORY ACTIVITY OF A VARIETY OF MELATONIN ANALOGS [J].
FLAUGH, ME ;
CROWELL, TA ;
CLEMENS, JA ;
SAWYER, BD .
JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (01) :63-69
[7]   4-[2-(DI-NORMAL-PROPYLAMINO)ETHYL]-2(3H)-INDOLONE - A PREJUNCTIONAL DOPAMINE RECEPTOR AGONIST [J].
GALLAGHER, G ;
LAVANCHY, PG ;
WILSON, JW ;
HIEBLE, JP ;
DEMARINIS, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (10) :1533-1536
[8]   DOPAMINE-RECEPTORS - FUNCTIONS, SUBTYPES AND EMERGING CONCEPTS [J].
KAISER, C ;
JAIN, T .
MEDICINAL RESEARCH REVIEWS, 1985, 5 (02) :145-229
[9]  
KAISER C, 1984, DOPAMINE RECEPTOR AG, P104
[10]   THE CHEMISTRY AND BIOLOGY OF RING-FLUORINATED BIOGENIC-AMINES [J].
KIRK, KL ;
CREVELING, CR .
MEDICINAL RESEARCH REVIEWS, 1984, 4 (02) :189-220